4 Results for "

DOCK5 Inhibitors

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "DOCK5 Inhibitors" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-110100
CAS No.: 310460-39-0
Purity:  99.94%
Target:  

DOCK

Research Areas:  

Inflammation/Immunology

CPYPP is a DOCK2-Rac1 interaction inhibitor. CPYPP binds to DOCK2 DHR-2 domain and inhibits the guanine nucleotide exchange factor (GEF) activity of DOCK2 DHR-2 for Rac1 in a dose-dependent manner with an IC50 of 22.8 µM. CPYPP also inhibits DOCK180 and DOCK5 and less inhibits DOCK9 .
loading...
    loading...
Cat. No.: HY-171274
CAS No.: 149775-26-8
Target:  

DOCK

Research Areas:  

Metabolic Disease

DOCK5-IN-1 (Compound 14) is the inhibitor for DOCK5 and exhibits no toxicity (100 μM) in cell RAW264.7 .
loading...
    loading...
Cat. No.: HY-164587
CAS No.: 2378515-04-7
Target:  

DOCK

Research Areas:  

Metabolic Disease

E197 is the inhibitor for DOCK5 that destroys the podosome belt structure of osteoclasts, thereby inhibiting the bone resorption (IC50=3.44 μM in human osteoclast). E197 inhibits the Rac in DOCK5 expressing HEK293 cell with an IC50 of 36 μM. E197 prevents the bone loss in mouse ovariectomized models .
loading...
    loading...
Cat. No.: HY-110100R
CAS No.: 310460-39-0
Research Areas:  

Inflammation/Immunology

CPYPP (Standard) is the analytical standard of CPYPP (HY-110100). This product is intended for research and analytical applications. CPYPP is a DOCK2-Rac1 interaction inhibitor. CPYPP binds to DOCK2 DHR-2 domain and inhibits the guanine nucleotide exchange factor (GEF) activity of DOCK2DHR-2 for Rac1 in a dose-dependent manner with an IC50 of 22.8 μM. CPYPP also inhibits DOCK180 and DOCK5 and less inhibits DOCK9 .
loading...
    loading...